Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A U.S. Retrospective Database Analysis Evaluating the Comparative Effectiveness of Budesonide/Formoterol Combination (BFC) and Fluticasone Propionate/Salmeterol Combination (FSC) Among Asthma Patients

NCT01623544 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01623544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01623544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A U.S. Retrospective Database Analysis Evaluating the Comparative Effectiveness of Budesonide/Formoterol Combination (BFC) and Fluticasone Propionate/Salmeterol Combination (FSC) Among Asthma Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
September 30, 2012
Enrollment
6,086 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma